| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.795 | 10.159 | 4.580 | 432 | 916 | 663 | 483 | 529 | 0 | 0 |
| Total Income - EUR | 13.796 | 10.159 | 4.580 | 432 | 1.050 | 663 | 483 | 529 | 0 | 0 |
| Total Expenses - EUR | 16.632 | 9.235 | 5.592 | 865 | 1.887 | 665 | 1.085 | 1.235 | 702 | 601 |
| Gross Profit/Loss - EUR | -2.836 | 924 | -1.012 | -433 | -837 | -2 | -602 | -705 | -702 | -601 |
| Net Profit/Loss - EUR | -3.250 | 619 | -1.150 | -446 | -863 | -21 | -616 | -721 | -702 | -601 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Loral Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 312 | 225 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 21.095 | 14.557 | 7.191 | 5.946 | 5.207 | 5.080 | 4.707 | 3.629 | 2.845 | 2.284 |
| Inventories | 657 | 495 | 535 | 445 | 126 | 205 | 149 | 0 | 0 | 0 |
| Receivables | 4.973 | 3.101 | 654 | 506 | 451 | 463 | 483 | 531 | 638 | 746 |
| Cash | 15.465 | 10.961 | 6.002 | 4.994 | 4.630 | 4.413 | 4.075 | 3.098 | 2.207 | 1.538 |
| Shareholders Funds | 12.371 | 8.410 | 2.509 | 2.017 | 1.116 | 1.073 | 434 | -286 | -987 | -1.583 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.134 | 6.372 | 4.682 | 3.929 | 4.091 | 4.014 | 4.289 | 3.915 | 3.832 | 3.867 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Loral Medical Srl